Related by context. Frequent words. (Click for all words.) 72 Investigational 71 IND submission 68 Investigational Device Exemption 67 Biologics License Application BLA 67 Marketing Authorization Application 66 Biologics License Application 65 Marketing Authorization Application MAA 65 supplemental Biologics License Application 64 INDs 64 IND enabling 64 BLA submission 63 Investigational Device Exemption IDE 63 Phase III Clinical Trial 63 New Drug IND 62 registrational 62 sBLA 62 Pivotal Phase III 61 phase IIa 61 Phase IIa trial 61 NDA submission 60 Phase IIa clinical trials 60 IND 60 orphan designation 60 alogliptin 60 Mutual Recognition Procedure 59 Act PDUFA date 59 registrational trial 59 Complete Response 59 New Drug Application 59 Vilazodone 59 Drug Application 58 confirmatory Phase 3 58 ANDAs 58 Approvable Letter 58 confirmatory Phase III 58 ponatinib 58 alvimopan 58 Orphan Drug status 57 anticancer compound 57 Complete Response letter 57 Rhucin ® 57 MONOVISC 57 QRxPharma 57 SFDA approval 57 Orphan Drug Status 57 Orphan Drug designation 57 Pivotal Trial 57 ICA # 57 sodium Injection 57 HCV protease inhibitor 57 Fast Track Designation 57 Phase 2b study 57 sNDA 57 Fast Track designation 57 Phase IIb 57 Phase 2a clinical 57 Phase III clinical 57 Phase IIa clinical 57 PDUFA date 57 Phase IIa 57 Pivotal Phase 57 PREOS 56 Apricus Bio 56 Nasdaq VRTX 56 vilazodone 56 Pirfenidone 56 BioDelivery Sciences 56 phase 2a 56 ATryn R 56 Phase 1b clinical 56 Diamyd ® 56 DAVANAT ® 56 PROPEL trial 56 phase IIb 56 deforolimus 56 Phenoptin 56 Drug Candidate 56 Virulizin R 56 KNS # 56 TOCOSOL Paclitaxel 55 prGCD 55 silodosin 55 Phase III 55 Marketing Authorization 55 Phase III clinical trials 55 ATryn ® 55 Completes Enrollment 55 Restanza 55 maribavir 55 Phase Ib 55 BEMA Fentanyl 55 Paragraph IV 55 Tranzyme Pharma 55 Phase 2b trial 55 SPD# 55 Phase 2a trial 55 pseudobulbar affect PBA 55 Phase 1b trial 55 methylnaltrexone 55 Phase III Trial 55 Phase 2b clinical